151 related articles for article (PubMed ID: 35940235)
1. H
Turhan K; Alan E; Yetik-Anacak G; Sevin G
Eur J Pharmacol; 2022 Sep; 931():175182. PubMed ID: 35940235
[TBL] [Abstract][Full Text] [Related]
2. H
Feng S; Chen S; Yu W; Zhang D; Zhang C; Tang C; Du J; Jin H
Lab Invest; 2017 Mar; 97(3):268-278. PubMed ID: 27941756
[TBL] [Abstract][Full Text] [Related]
3. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
4. Nitroso-sulfide coupled signaling triggers specific vasoactive effects in the intrarenal arteries of patients with arterial hypertension.
Cacanyiova S; Berenyiova A; Balis P; Kristek F; Grman M; Ondrias K; Breza J; Breza J
J Physiol Pharmacol; 2017 Aug; 68(4):527-538. PubMed ID: 29151069
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.
Rakotoniaina Z; Guerard P; Lirussi F; Rochette L; Dumas M; Goirand F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2008 Sep; 378(3):241-51. PubMed ID: 18542928
[TBL] [Abstract][Full Text] [Related]
6. [Angiotensin-(1-7) improves endothelium-dependent vasodilation in rats with monocrotaline-induced pulmonary arterial hypertension].
Liu XX; Chen AD; Pan Y; Zhang F; Qi ZB; Cao N; Han Y
Sheng Li Xue Bao; 2023 Aug; 75(4):497-502. PubMed ID: 37583036
[TBL] [Abstract][Full Text] [Related]
7. GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and K
Abramavicius S; Petersen AG; Renaltan NS; Prat-Duran J; Torregrossa R; Stankevicius E; Whiteman M; Simonsen U
Front Pharmacol; 2021; 12():613989. PubMed ID: 33841145
[TBL] [Abstract][Full Text] [Related]
8. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.
Baber SR; Deng W; Master RG; Bunnell BA; Taylor BK; Murthy SN; Hyman AL; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1120-8. PubMed ID: 16980338
[TBL] [Abstract][Full Text] [Related]
9. Impaired endothelium-dependent relaxation by adrenomedullin in monocrotaline-treated rat arteries.
Gout B; Quiniou MJ; Khandoudi N; Le Dantec C; Saïag B
Eur J Pharmacol; 1999 Sep; 380(1):23-30. PubMed ID: 10513556
[TBL] [Abstract][Full Text] [Related]
10. Endogenous hydrogen sulfide sulfhydrates IKKβ at cysteine 179 to control pulmonary artery endothelial cell inflammation.
Zhang D; Wang X; Chen S; Chen S; Yu W; Liu X; Yang G; Tao Y; Tang X; Bu D; Zhang H; Kong W; Tang C; Huang Y; Du J; Jin H
Clin Sci (Lond); 2019 Oct; 133(20):2045-2059. PubMed ID: 31654061
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the endothelial functions in monocrotaline-induced pulmonary hypertension.
Sirmagul B; Ilgin S; Atli O; Usanmaz SE; Demirel-Yilmaz E
Clin Exp Hypertens; 2013; 35(3):220-7. PubMed ID: 22967272
[TBL] [Abstract][Full Text] [Related]
13. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
[TBL] [Abstract][Full Text] [Related]
14. [Impact of hydrogen sulfide donor on pulmonary vascular structure and vasoactive peptides in rats with pulmonary hypertension induced by high pulmonary blood flow].
Li XH; Du JB; Tang CS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):159-63. PubMed ID: 16733895
[TBL] [Abstract][Full Text] [Related]
15. Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide.
Swan KW; Song BM; Chen AL; Chen TJ; Chan RA; Guidry BT; Katakam PVG; Kerut EK; Giles TD; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2017 Oct; 313(4):H732-H743. PubMed ID: 28667054
[TBL] [Abstract][Full Text] [Related]
16. Eulophia macrobulbon extract relaxes rat isolated pulmonary artery and protects against monocrotaline-induced pulmonary arterial hypertension.
Wisutthathum S; Demougeot C; Totoson P; Adthapanyawanich K; Ingkaninan K; Temkitthawon P; Chootip K
Phytomedicine; 2018 Nov; 50():157-165. PubMed ID: 30466974
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
Zhang H; Lin Y; Ma Y; Zhang J; Wang C; Zhang H
Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044
[TBL] [Abstract][Full Text] [Related]
18. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
[TBL] [Abstract][Full Text] [Related]
19. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
Varshney R; Ali Q; Wu C; Sun Z
Hypertension; 2016 Nov; 68(5):1255-1263. PubMed ID: 27672025
[TBL] [Abstract][Full Text] [Related]
20. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
